I
iovera
MyoScience develops and commercializes technology-driven dermatological products
About iovera
Myoscience operates in the medical technology sector, specializing in cryoanalgesia solutions designed to provide immediate and long-lasting non-opioid pain relief. The company's core product is a handheld device that targets both superficial and deep nerves, making it suitable for various clinical settings. Myoscience primarily serves healthcare providers, including doctors and clinics, who incorporate their technology into pain management practices. The business model revolves around selling these advanced medical devices and offering comprehensive support and resources to healthcare professionals for effective implementation. Revenue is generated through direct sales of the devices and potentially through service agreements for ongoing support and training.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2005
- Headquarters
- Fremont, United States
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 37.6/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Charity, Accounting, Intellectual Property, Testing, Verification, Risk Management, Biotechnology, Neurology, Dermatology
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| FundingOther financing | Jun 2026 | $70M | — | Zimmer Biomet | ↗ |
| ACQUISITIONOther financing | Mar 2019 | $220M | $220M | Pacira Biosciences | — |
Growth signals
Latest recorded traffic for iovera is 5.3K monthly website visits. iovera's team declined 14.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- NPNexus Medical Partners
- SVSaratoga Ventures
- DVDeNovo Ventures
- AVAccuitive Medical Ventures
Valiance Asset Management
Series B and later1 investor entered at this stage
- MCMedicis Capital
Other known investors2 additional known investors
Pacira Biosciences
Zimmer Biomet
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about iovera on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See iovera’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






